首頁 > 市場調查報告書 > 醫療設備

體外診斷生技設備

市場調查報告書

商品編碼

1792741

全球分子醫學市場

Molecular Pharming

出版日期: 2025年08月18日 | 出版商:

Global Industry Analysts, Inc. | 英文 495 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2030年，全球分子醫學市場規模將達23億美元

全球分子藥物市場規模預計在2024年為17億美元，預計到2030年將達到23億美元，2024年至2030年的複合年成長率為5.9%。玉米作物是本報告分析的細分市場之一，預計其複合年成長率為5.0%，到分析期結束時將達到6.074億美元。大麥作物細分市場在分析期間的複合年成長率預計為4.6%。

美國市場規模估計為 4.498 億美元，而中國市場預計複合年成長率為 9.1%

美國分子藥物市場規模預計2024年達到4.498億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到4.683億美元，在2024-2030年的分析期間內，複合年成長率為9.1%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個國家的複合年成長率分別為3.0%和5.7%。在歐洲，預計德國的複合年成長率為3.8%。

全球分子製藥市場－主要趨勢與促進因素摘要

什麼是分子藥理學？

分子藥學是指利用基因改造植物生產疫苗、抗體、酵素和治療性蛋白質等藥物。該技術將植物生物技術與製藥製造相結合，使植物能夠充當複雜生技藥品的生物工廠。分子藥學因其有可能為傳統的細胞和微生物生產系統提供一種可擴展、低成本且耐污染的替代方案而備受關注。

利用菸草、玉米、水稻甚至生菜等作物，研究人員可以表達編碼治療性蛋白質的特定基因。這些蛋白質隨後被收穫並純化用於醫療用途。分子製藥學尤其適合大量生產生技藥品，尤其是在資源匱乏的地區和衛生緊急情況下，快速、經濟高效的生產至關重要。其重要性在於它能夠滿足全球日益成長的生技藥品需求，同時規避傳統生產基礎設施的限制。

該領域的技術和流程如何發展？

基因工程、植物轉化技術和蛋白質表現系統的進步顯著提高了分子藥物的效率和可行性。農桿菌介導的基因轉移、基於病毒載體的瞬時表達以及基於CRISPR的基因編輯等技術有助於最佳化產量並縮短開發時間。純化製程也得到了發展，新的方法能夠在不損害結構或功能的情況下回收高純度的蛋白質。

單株抗體、胰島素類似物和酵素替代療法現在可以直接在植物組織中表現。為了保持一致性並滿足藥品級標準，一些方法在封閉迴路境中使用水耕植物。法律規範正在逐步調整以支持商業性規模化生產，多種植物來源生技藥品已核准使用。這些進展增強了人們對植物來源生產系統的信心，尤其是在利基市場或大規模治療需求方面。

分子藥理學的應用領域在哪裡？主要的相關人員是誰？

分子藥理學在疫苗研發、感染疾病治療、癌症治療和罕見遺傳疾病等多個領域都有應用。其中一個主要的成功案例是生產針對伊波拉和狂犬病毒的抗體。研究機構、生技公司和製藥公司正在投資植物來源的平台，以豐富生物製藥產品線，並應對不斷變化的全球衛生重點。

學術研究中心在早期開發和概念驗證研究中發揮核心作用，而私人公司則專注於規模化生產、配方研發和監管核准。開發中地區的政府和衛生組織將分子藥理學視為在基本藥物生產方面實現更大程度自力更生的手段。公共機構與生技公司之間的夥伴關係正變得越來越普遍，尤其是在生產疫苗和治療方法傳統模式下缺乏商業性獎勵的疾病方面。

哪些因素推動了分子藥物市場的成長？

分子製藥市場的成長受到多種因素的驅動，包括對生技藥品日益成長的需求、傳統製造系統的局限性以及對靈活可擴展製造平台的需求。分子製藥在基礎設施和原料方面具有成本優勢，使其在開發中國家生產價格合理的治療藥物方面具有吸引力。能夠快速擴大生產規模以應對新興感染疾病是另一個吸引人們注意的關鍵優勢。

植物生物技術的進步、合成生物學投資的增加以及下游純化技術的進步，正在幫助克服過去在產量和一致性方面的限制。監管和公共衛生機構日益成長的支持也推動了其更廣泛的應用。隨著全球醫療保健系統尋求具有彈性和分散式的生產解決方案，分子製藥正逐漸成為一種可行方法，以更快、永續滿足未來的治療需求。

部分

作物來源（玉米作物、大麥作物、菸草作物、紅花作物、水稻作物、紫花苜蓿作物）、技術（基因槍技術、農業滲透技術、電穿孔技術、農桿菌介導的基因轉移技術、其他技術）、用途（重組抗體用途、激素用途、疫苗用途、工業酶用途、蛋白質/蛋白質基材料用途、技術試劑、其他製藥公司

受訪公司範例

Agrenvec SL
Avaxin Biologics
Baiya Phytopharm
BioBetter Ltd.
Bright Biotech
Cape Bio Pharms（Cape Biologix Tech.）
Diamante Srl
Elo Life Systems
Leaf Expression Systems
Medicago Inc.
Miruku
Moolec Science SA
MOZZA（Mozza Foods）
Nobell Foods
ORF Genetics hf.
PlantForm Corporation
Planet Biotechnology Inc.
ProdiGene Inc.
Protalix Biotherapeutics, Inc.
Tiamat Sciences Corp.

人工智慧整合

全球產業分析師利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global Industry Analysts 沒有遵循典型的 LLM 或特定於行業的 SLM查詢，而是建立了一個從世界各地的專家收集的內容庫，其中包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

The global market for Molecular Pharming estimated at US$1.7 Billion in the year 2024, is expected to reach US$2.3 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2024-2030. Maize Crop, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$607.4 Million by the end of the analysis period. Growth in the Barley Crop segment is estimated at 4.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$449.8 Million While China is Forecast to Grow at 9.1% CAGR

The Molecular Pharming market in the U.S. is estimated at US$449.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$468.3 Million by the year 2030 trailing a CAGR of 9.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.0% and 5.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Molecular Pharming Market - Key Trends & Drivers Summarized

What Is Molecular Pharming and Why Is It Gaining Momentum?

Molecular pharming refers to the use of genetically modified plants to produce pharmaceutical substances such as vaccines, antibodies, enzymes, and therapeutic proteins. This technique combines plant biotechnology with pharmaceutical manufacturing, allowing plants to function as biofactories for complex biologics. Molecular pharming is gaining attention for its potential to offer scalable, low-cost, and contamination-resistant alternatives to traditional cell-based or microbial production systems.

By using crops such as tobacco, maize, rice, and even lettuce, researchers can express specific genes that encode therapeutic proteins. These proteins are then harvested and purified for medical use. Molecular pharming is particularly suited for producing biologics in large volumes, especially in low-resource settings or during health emergencies where rapid and cost-effective manufacturing is critical. Its growing relevance lies in its ability to meet rising global demand for biologics while bypassing the limitations of conventional production infrastructure.

How Are Technologies and Processes Advancing in This Field?

Advancements in genetic engineering, plant transformation techniques, and protein expression systems have significantly improved the efficiency and viability of molecular pharming. Technologies such as Agrobacterium-mediated gene transfer, transient expression using viral vectors, and CRISPR-based gene editing are helping optimize yields and reduce development time. Purification processes have also evolved, with new methods enabling the recovery of high-purity proteins without damaging their structure or function.

Innovations now allow expression of monoclonal antibodies, insulin analogs, and enzyme replacement therapies directly within plant tissues. Some approaches use hydroponically grown plants in contained environments to maintain consistency and meet pharmaceutical-grade standards. Regulatory frameworks are gradually adapting to support commercial scale-up, with a few plant-derived biologics already approved for use. These developments are expanding confidence in plant-based production systems, especially for niche or high-volume therapeutic needs.

Where Is Molecular Pharming Being Applied and Who Are the Key Stakeholders?

Molecular pharming is being applied in several areas including vaccine development, infectious disease treatment, cancer therapy, and rare genetic disorders. One of its major successes has been the production of antibodies against Ebola and rabies viruses. Research institutions, biotech firms, and pharmaceutical companies are investing in plant-based platforms to diversify their biologics pipelines and respond to evolving global health priorities.

Academic research centers play a central role in early-stage development and proof-of-concept studies, while private-sector players focus on scale-up, formulation, and regulatory approval. Governments and health organizations in developing regions view molecular pharming as a means to achieve greater self-reliance in essential medicine production. Partnerships between public institutions and biotech companies are becoming more common, especially for producing vaccines and treatments for diseases that lack commercial incentives under traditional models.

What Factors Are Driving Growth In The Molecular Pharming Market?

Growth in the molecular pharming market is driven by several factors including rising demand for biologics, limitations of traditional manufacturing systems, and the need for flexible, scalable production platforms. Molecular pharming offers cost advantages in terms of infrastructure and raw materials, making it attractive for producing affordable therapies in developing countries. The ability to rapidly deploy production in response to emerging infectious diseases is another key benefit driving interest.

Advances in plant biotechnology, increased investment in synthetic biology, and progress in downstream purification technologies are helping overcome past limitations related to yield and consistency. Growing support from regulatory bodies and public health institutions is also encouraging wider adoption. As global healthcare systems look for resilient and decentralized manufacturing solutions, molecular pharming is emerging as a viable approach to meeting future therapeutic needs with greater speed and sustainability.

SCOPE OF STUDY:

The report analyzes the Molecular Pharming market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Crop Source (Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop, Alfalfa Crop); Technology (Gene Gun Technology, Agro infiltration Technology, Electroporation Technology, Agrobacterium-Mediated Gene Transfer Technology, Other Technologies); Application (Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application, Other Applications); End-Use (Biotech & Pharma Companies End-Use, CROs End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 39 Featured) -

Agrenvec S.L.
Avaxin Biologics
Baiya Phytopharm
BioBetter Ltd.
Bright Biotech
Cape Bio Pharms (Cape Biologix Tech.)
Diamante S.r.l.
Elo Life Systems
Leaf Expression Systems
Medicago Inc.
Miruku
Moolec Science SA
MOZZA (Mozza Foods)
Nobell Foods
ORF Genetics hf.
PlantForm Corporation
Planet Biotechnology Inc.
ProdiGene Inc.
Protalix Biotherapeutics, Inc.
Tiamat Sciences Corp.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Tariff Impact on Global Supply Chain Patterns
- Molecular Pharming - Global Key Competitors Percentage Market Share in 2025 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Growing Demand for Cost-Effective Biopharmaceuticals Propels Adoption of Molecular Pharming Technologies
- Rising Interest in Plant-Based Protein Expression Systems Strengthens Business Case for Alternative Drug Production
- Expansion of Therapeutic Protein and Vaccine Development Drives Innovation in Molecular Pharming Platforms
- Reduced Risk of Human Pathogen Contamination in Plant Systems Accelerates Regulatory Acceptance
- Technological Advancements in Gene Editing and Plant Transformation Enhance Efficiency and Product Yield
- Growth in Monoclonal Antibody Research Fuels Demand for Scalable Plant-Based Expression Systems
- Increasing Pressure to Lower Biologic Drug Production Costs Spurs Investment in Molecular Pharming Startups
- Global Vaccine Access Initiatives Highlight Potential of Plant-Derived Vaccines for Rapid, Scalable Deployment
- Expansion of Biodefense and Pandemic Preparedness Programs Throws Spotlight on Fast-Track Production Methods
- Growing Need for Cold Chain-Free Biologics Enhances Suitability of Plant-Based Pharmaceutical Products
- Increased Application of Molecular Pharming in Veterinary Biologics Broadens End-Use Market Scope
- Demand for Plant-Derived Enzymes and Industrial Proteins Drives Cross-Sector Adoption
4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Molecular Pharming Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
- TABLE 2: World Recent Past, Current & Future Analysis for Molecular Pharming by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 3: World Historic Review for Molecular Pharming by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 4: World 16-Year Perspective for Molecular Pharming by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
- TABLE 5: World Recent Past, Current & Future Analysis for Maize Crop by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 6: World Historic Review for Maize Crop by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 7: World 16-Year Perspective for Maize Crop by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 8: World Recent Past, Current & Future Analysis for Barley Crop by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 9: World Historic Review for Barley Crop by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 10: World 16-Year Perspective for Barley Crop by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 11: World Recent Past, Current & Future Analysis for Tobacco Crop by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 12: World Historic Review for Tobacco Crop by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 13: World 16-Year Perspective for Tobacco Crop by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 14: World Recent Past, Current & Future Analysis for Safflower Crop by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 15: World Historic Review for Safflower Crop by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 16: World 16-Year Perspective for Safflower Crop by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 17: World Recent Past, Current & Future Analysis for Rice Crop by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 18: World Historic Review for Rice Crop by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 19: World 16-Year Perspective for Rice Crop by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 20: World Recent Past, Current & Future Analysis for Alfalfa Crop by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 21: World Historic Review for Alfalfa Crop by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 22: World 16-Year Perspective for Alfalfa Crop by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 23: World Recent Past, Current & Future Analysis for Agrobacterium-Mediated Gene Transfer Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 24: World Historic Review for Agrobacterium-Mediated Gene Transfer Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 25: World 16-Year Perspective for Agrobacterium-Mediated Gene Transfer Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 26: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 27: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 28: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 29: World Recent Past, Current & Future Analysis for Gene Gun Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 30: World Historic Review for Gene Gun Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 31: World 16-Year Perspective for Gene Gun Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 32: World Recent Past, Current & Future Analysis for Agro infiltration Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 33: World Historic Review for Agro infiltration Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 34: World 16-Year Perspective for Agro infiltration Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 35: World Recent Past, Current & Future Analysis for Electroporation Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 36: World Historic Review for Electroporation Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 37: World 16-Year Perspective for Electroporation Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 38: World Recent Past, Current & Future Analysis for Recombinant Antibodies Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 39: World Historic Review for Recombinant Antibodies Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 40: World 16-Year Perspective for Recombinant Antibodies Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 41: World Recent Past, Current & Future Analysis for Hormones Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 42: World Historic Review for Hormones Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 43: World 16-Year Perspective for Hormones Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 44: World Recent Past, Current & Future Analysis for Vaccines Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 45: World Historic Review for Vaccines Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 46: World 16-Year Perspective for Vaccines Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 47: World Recent Past, Current & Future Analysis for Industrial Enzymes Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 48: World Historic Review for Industrial Enzymes Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 49: World 16-Year Perspective for Industrial Enzymes Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 50: World Recent Past, Current & Future Analysis for Proteins & Protein-based Materials Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 51: World Historic Review for Proteins & Protein-based Materials Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 52: World 16-Year Perspective for Proteins & Protein-based Materials Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 53: World Recent Past, Current & Future Analysis for Technical Reagents Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 54: World Historic Review for Technical Reagents Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 55: World 16-Year Perspective for Technical Reagents Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 56: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 57: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 58: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 59: World Recent Past, Current & Future Analysis for Biotech & Pharma Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 60: World Historic Review for Biotech & Pharma Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 61: World 16-Year Perspective for Biotech & Pharma Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 62: World Recent Past, Current & Future Analysis for CROs End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 63: World Historic Review for CROs End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 64: World 16-Year Perspective for CROs End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 65: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 66: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 67: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

UNITED STATES
- Molecular Pharming Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
- TABLE 68: USA Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 69: USA Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 70: USA 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
- TABLE 71: USA Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 72: USA Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 73: USA 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
- TABLE 74: USA Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 75: USA Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 76: USA 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 77: USA Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 78: USA Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 79: USA 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
CANADA
- TABLE 80: Canada Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 81: Canada Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 82: Canada 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
- TABLE 83: Canada Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 84: Canada Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 85: Canada 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
- TABLE 86: Canada Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 87: Canada Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 88: Canada 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 89: Canada Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 90: Canada Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 91: Canada 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
JAPAN
- Molecular Pharming Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
- TABLE 92: Japan Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 93: Japan Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 94: Japan 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
- TABLE 95: Japan Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 96: Japan Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 97: Japan 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
- TABLE 98: Japan Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 99: Japan Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 100: Japan 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 101: Japan Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 102: Japan Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 103: Japan 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
CHINA
- Molecular Pharming Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
- TABLE 104: China Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 105: China Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 106: China 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
- TABLE 107: China Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 108: China Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 109: China 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
- TABLE 110: China Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 111: China Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 112: China 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 113: China Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 114: China Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 115: China 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
EUROPE
- Molecular Pharming Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
- TABLE 116: Europe Recent Past, Current & Future Analysis for Molecular Pharming by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 117: Europe Historic Review for Molecular Pharming by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 118: Europe 16-Year Perspective for Molecular Pharming by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
- TABLE 119: Europe Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 120: Europe Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 121: Europe 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
- TABLE 122: Europe Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 123: Europe Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 124: Europe 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
- TABLE 125: Europe Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 126: Europe Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 127: Europe 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 128: Europe Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 129: Europe Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 130: Europe 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
FRANCE
- Molecular Pharming Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
- TABLE 131: France Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 132: France Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 133: France 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
- TABLE 134: France Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 135: France Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 136: France 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
- TABLE 137: France Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 138: France Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 139: France 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 140: France Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 141: France Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 142: France 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
GERMANY
- Molecular Pharming Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
- TABLE 143: Germany Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 144: Germany Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 145: Germany 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
- TABLE 146: Germany Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 147: Germany Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 148: Germany 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
- TABLE 149: Germany Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 150: Germany Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 151: Germany 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 152: Germany Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 153: Germany Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 154: Germany 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
ITALY
- TABLE 155: Italy Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 156: Italy Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 157: Italy 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
- TABLE 158: Italy Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 159: Italy Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 160: Italy 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
- TABLE 161: Italy Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 162: Italy Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 163: Italy 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 164: Italy Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 165: Italy Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 166: Italy 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
UNITED KINGDOM
- Molecular Pharming Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
- TABLE 167: UK Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 168: UK Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 169: UK 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
- TABLE 170: UK Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 171: UK Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 172: UK 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
- TABLE 173: UK Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 174: UK Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 175: UK 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 176: UK Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 177: UK Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 178: UK 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
SPAIN
- TABLE 179: Spain Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 180: Spain Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 181: Spain 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
- TABLE 182: Spain Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 183: Spain Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 184: Spain 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
- TABLE 185: Spain Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 186: Spain Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 187: Spain 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 188: Spain Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 189: Spain Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 190: Spain 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
RUSSIA
- TABLE 191: Russia Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 192: Russia Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 193: Russia 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
- TABLE 194: Russia Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 195: Russia Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 196: Russia 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
- TABLE 197: Russia Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 198: Russia Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 199: Russia 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 200: Russia Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 201: Russia Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 202: Russia 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
REST OF EUROPE
- TABLE 203: Rest of Europe Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 204: Rest of Europe Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 205: Rest of Europe 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
- TABLE 206: Rest of Europe Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 207: Rest of Europe Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 208: Rest of Europe 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
- TABLE 209: Rest of Europe Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 210: Rest of Europe Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 211: Rest of Europe 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 212: Rest of Europe Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 213: Rest of Europe Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 214: Rest of Europe 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
ASIA-PACIFIC
- Molecular Pharming Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
- TABLE 215: Asia-Pacific Recent Past, Current & Future Analysis for Molecular Pharming by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 216: Asia-Pacific Historic Review for Molecular Pharming by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 217: Asia-Pacific 16-Year Perspective for Molecular Pharming by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
- TABLE 218: Asia-Pacific Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 219: Asia-Pacific Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 220: Asia-Pacific 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
- TABLE 221: Asia-Pacific Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 222: Asia-Pacific Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 223: Asia-Pacific 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
- TABLE 224: Asia-Pacific Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 225: Asia-Pacific Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 226: Asia-Pacific 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 227: Asia-Pacific Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 228: Asia-Pacific Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 229: Asia-Pacific 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
AUSTRALIA
- Molecular Pharming Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
- TABLE 230: Australia Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 231: Australia Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 232: Australia 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
- TABLE 233: Australia Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 234: Australia Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 235: Australia 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
- TABLE 236: Australia Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 237: Australia Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 238: Australia 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 239: Australia Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 240: Australia Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 241: Australia 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
INDIA
- Molecular Pharming Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
- TABLE 242: India Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 243: India Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 244: India 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
- TABLE 245: India Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 246: India Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 247: India 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
- TABLE 248: India Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 249: India Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 250: India 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 251: India Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 252: India Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 253: India 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
SOUTH KOREA
- TABLE 254: South Korea Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 255: South Korea Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 256: South Korea 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
- TABLE 257: South Korea Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 258: South Korea Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 259: South Korea 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
- TABLE 260: South Korea Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 261: South Korea Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 262: South Korea 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 263: South Korea Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 264: South Korea Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 265: South Korea 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
REST OF ASIA-PACIFIC
- TABLE 266: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 267: Rest of Asia-Pacific Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 268: Rest of Asia-Pacific 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
- TABLE 269: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 270: Rest of Asia-Pacific Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 271: Rest of Asia-Pacific 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
- TABLE 272: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 273: Rest of Asia-Pacific Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 274: Rest of Asia-Pacific 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 275: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 276: Rest of Asia-Pacific Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 277: Rest of Asia-Pacific 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
LATIN AMERICA
- Molecular Pharming Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
- TABLE 278: Latin America Recent Past, Current & Future Analysis for Molecular Pharming by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 279: Latin America Historic Review for Molecular Pharming by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 280: Latin America 16-Year Perspective for Molecular Pharming by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
- TABLE 281: Latin America Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 282: Latin America Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 283: Latin America 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
- TABLE 284: Latin America Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 285: Latin America Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 286: Latin America 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
- TABLE 287: Latin America Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 288: Latin America Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 289: Latin America 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 290: Latin America Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 291: Latin America Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 292: Latin America 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
ARGENTINA
- TABLE 293: Argentina Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 294: Argentina Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 295: Argentina 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
- TABLE 296: Argentina Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 297: Argentina Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 298: Argentina 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
- TABLE 299: Argentina Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 300: Argentina Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 301: Argentina 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 302: Argentina Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 303: Argentina Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 304: Argentina 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
BRAZIL
- TABLE 305: Brazil Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 306: Brazil Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 307: Brazil 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
- TABLE 308: Brazil Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 309: Brazil Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 310: Brazil 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
- TABLE 311: Brazil Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 312: Brazil Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 313: Brazil 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 314: Brazil Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 315: Brazil Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 316: Brazil 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
MEXICO
- TABLE 317: Mexico Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 318: Mexico Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 319: Mexico 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
- TABLE 320: Mexico Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 321: Mexico Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 322: Mexico 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
- TABLE 323: Mexico Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 324: Mexico Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 325: Mexico 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 326: Mexico Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 327: Mexico Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 328: Mexico 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
REST OF LATIN AMERICA
- TABLE 329: Rest of Latin America Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 330: Rest of Latin America Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 331: Rest of Latin America 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
- TABLE 332: Rest of Latin America Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 333: Rest of Latin America Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 334: Rest of Latin America 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
- TABLE 335: Rest of Latin America Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 336: Rest of Latin America Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 337: Rest of Latin America 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 338: Rest of Latin America Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 339: Rest of Latin America Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 340: Rest of Latin America 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
MIDDLE EAST
- Molecular Pharming Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
- TABLE 341: Middle East Recent Past, Current & Future Analysis for Molecular Pharming by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 342: Middle East Historic Review for Molecular Pharming by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 343: Middle East 16-Year Perspective for Molecular Pharming by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
- TABLE 344: Middle East Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 345: Middle East Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 346: Middle East 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
- TABLE 347: Middle East Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 348: Middle East Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 349: Middle East 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
- TABLE 350: Middle East Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 351: Middle East Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 352: Middle East 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 353: Middle East Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 354: Middle East Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 355: Middle East 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
IRAN
- TABLE 356: Iran Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 357: Iran Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 358: Iran 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
- TABLE 359: Iran Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 360: Iran Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 361: Iran 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
- TABLE 362: Iran Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 363: Iran Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 364: Iran 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 365: Iran Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 366: Iran Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 367: Iran 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
ISRAEL
- TABLE 368: Israel Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 369: Israel Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 370: Israel 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
- TABLE 371: Israel Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 372: Israel Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 373: Israel 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
- TABLE 374: Israel Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 375: Israel Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 376: Israel 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 377: Israel Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 378: Israel Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 379: Israel 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
SAUDI ARABIA
- TABLE 380: Saudi Arabia Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 381: Saudi Arabia Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 382: Saudi Arabia 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
- TABLE 383: Saudi Arabia Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 384: Saudi Arabia Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 385: Saudi Arabia 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
- TABLE 386: Saudi Arabia Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 387: Saudi Arabia Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 388: Saudi Arabia 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 389: Saudi Arabia Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 390: Saudi Arabia Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 391: Saudi Arabia 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
UNITED ARAB EMIRATES
- TABLE 392: UAE Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 393: UAE Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 394: UAE 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
- TABLE 395: UAE Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 396: UAE Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 397: UAE 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
- TABLE 398: UAE Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 399: UAE Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 400: UAE 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 401: UAE Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 402: UAE Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 403: UAE 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
REST OF MIDDLE EAST
- TABLE 404: Rest of Middle East Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 405: Rest of Middle East Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 406: Rest of Middle East 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
- TABLE 407: Rest of Middle East Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 408: Rest of Middle East Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 409: Rest of Middle East 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
- TABLE 410: Rest of Middle East Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 411: Rest of Middle East Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 412: Rest of Middle East 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 413: Rest of Middle East Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 414: Rest of Middle East Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 415: Rest of Middle East 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
AFRICA
- Molecular Pharming Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
- TABLE 416: Africa Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 417: Africa Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 418: Africa 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030
- TABLE 419: Africa Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 420: Africa Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 421: Africa 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030
- TABLE 422: Africa Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 423: Africa Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 424: Africa 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030
- TABLE 425: Africa Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 426: Africa Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 427: Africa 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030